Skip to content
Research Article Open access CC BY 3.0

Effect of Combined Quinine and Ciprofloxacin Therapy in Experimental Murine Plasmodiasis

Udobi Chinweizu Ejikeme, M. E. Ubulom Peace, Onwubiko Chinaza

International Journal of TROPICAL DISEASE & Health · pp. 344–351 · Published 18 Jan 2014

10.9734/IJTDH/2014/6788

Abstract

The increasing spread of drug-resistant malaria parasite has necessitated the continuous search for even more effective malaria treatment including the combination of drugs known to have significant anti malarial potentials. Effort in this study was therefore, devoted to evaluating in vivo, anti plasmodial activity of combination of varying doses (4.3, 8.6, 12.9 mg/kg body weight) of quinine (a known anti malarial gradually loosing relevance) with varying doses (5.0, 10.0, 15.0 mg/kg body weight) of ciprofloxacin (a fluoroquinolone commonly used to treat bacterial infections and has been shown to possess significant anti malarial activity both in vitro and in vivo) in Plasmodium berghei infected mice. Parasitological activity and survival of the animal were assessed over 21 days. Parasitemia in non-treated control mice peaked at 75% on day 9 and none survived by day 11. The lower dosages of quinine (4.3 and 8.6 mg/kg body weight) and ciprofloxacin (5.0 and 10.0 mg/kg body weight) were not efficient. However, the combination of 12.9 mg/kg body weight of quinine with 15 mg/kg body weight of ciprofloxacin achieved 87% reduction in parasitemia level and significantly reduced mortality in the infected animals compared with other treatment groups. The results from this study support the potential use of ciprofloxacin in combination with quinine for the treatment of resistant malaria.

Drug resistance combination Plasmodiums berghei quinine ciprofloxacin parasitaemia

References (8)

  1. 1 Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria [DOI]
  2. 2 The molecular basis of quinolone action [DOI]
  3. 3 ACT NOW OR LATER? ECONOMICS OF MALARIA RESISTANCE [DOI]
  4. 4 Emerging drug--resistance and guidelines for treatment of malaria.
  5. 5 Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin [DOI]
  6. 6 Activities of pefloxacin and ciprofloxacin against experimental malaria in mice [DOI]
  7. 7 Treatment of uncomplicated plasmodium falciparum malaria with quinine-doxycycline combination therapy.
  8. 8 Effect of Chloroquine on the Bioavailability of Ciprofloxacin in Humans [DOI]

Cited by 5

Inhibitory effects of novel ciprofloxacin derivatives on the growth of four Babesia species and Theileria equi

Gaber El-Saber Batiha, Dickson Stuart Tayebwa, Amany Magdy Beshbishy · Parasitology Research · 2020

Amodiaquine and Ciprofloxacin Combination in Plasmodiasis Therapy

Peace Mayen Edwin Ubulom, Chinweizu Ejikeme Udobi, Mark Iheukwumere Madu · Journal of Tropical Medicine · 2015

Showing 2 of 5 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

2

Page views

0

PDF downloads

0

Outbound clicks

5

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.